Literature DB >> 24080728

MicroRNA-155 broadly orchestrates inflammation-induced changes of microRNA expression in breast cancer.

Song Hu1, Wei Zhu2, Ling-Fei Zhang1, Ming Pei3, Mo-Fang Liu1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24080728      PMCID： PMC3915901          DOI： 10.1038/cr.2013.137

Source DB:  PubMed          Journal:  Cell Res        ISSN： 1001-0602            Impact factor:   25.617


× No keyword cloud information.
  9 in total

1.  The TRANSFAC system on gene expression regulation.

Authors:  E Wingender; X Chen; E Fricke; R Geffers; R Hehl; I Liebich; M Krull; V Matys; H Michael; R Ohnhäuser; M Prüss; F Schacherer; S Thiele; S Urbach
Journal:  Nucleic Acids Res       Date:  2001-01-01       Impact factor: 16.971

Review 2.  Immunity, inflammation, and cancer.

Authors:  Sergei I Grivennikov; Florian R Greten; Michael Karin
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

3.  MicroRNA 155 modulates megakaryopoiesis at progenitor and precursor level by targeting Ets-1 and Meis1 transcription factors.

Authors:  Paolo Romania; Valentina Lulli; Elvira Pelosi; Mauro Biffoni; Cesare Peschle; Giovanna Marziali
Journal:  Br J Haematol       Date:  2008-11       Impact factor: 6.998

4.  MicroRNA-155 functions as an OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene.

Authors:  Shuai Jiang; Hong-Wei Zhang; Ming-Hua Lu; Xiao-Hong He; Yong Li; Hua Gu; Mo-Fang Liu; En-Duo Wang
Journal:  Cancer Res       Date:  2010-03-30       Impact factor: 12.701

Review 5.  Targeting microRNAs in cancer: rationale, strategies and challenges.

Authors:  Ramiro Garzon; Guido Marcucci; Carlo M Croce
Journal:  Nat Rev Drug Discov       Date:  2010-10       Impact factor: 84.694

6.  A novel miR-155/miR-143 cascade controls glycolysis by regulating hexokinase 2 in breast cancer cells.

Authors:  Shuai Jiang; Ling-Fei Zhang; Hong-Wei Zhang; Song Hu; Ming-Hua Lu; Sheng Liang; Biao Li; Yong Li; Dangsheng Li; En-Duo Wang; Mo-Fang Liu
Journal:  EMBO J       Date:  2012-02-21       Impact factor: 11.598

Review 7.  Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways.

Authors:  Aaron J Schetter; Niels H H Heegaard; Curtis C Harris
Journal:  Carcinogenesis       Date:  2009-12-02       Impact factor: 4.944

Review 8.  miR-155: on the crosstalk between inflammation and cancer.

Authors:  Esmerina Tili; Carlo M Croce; Jean-Jacques Michaille
Journal:  Int Rev Immunol       Date:  2009       Impact factor: 5.311

Review 9.  MicroRNA and cancer--focus on apoptosis.

Authors:  Yu Wang; Caroline G L Lee
Journal:  J Cell Mol Med       Date:  2009-01       Impact factor: 5.310
  9 in total
  9 in total

Review 1.  Tracking miRNAs' footprints in tumor-microenvironment interactions: Insights and implications for targeted cancer therapy.

Authors:  Nazila Nouraee; Seyed Javad Mowla; George A Calin
Journal:  Genes Chromosomes Cancer       Date:  2015-03-31       Impact factor: 5.006

2.  miR-155 Is Essential for Inflammation-Induced Hippocampal Neurogenic Dysfunction.

Authors:  Maya E Woodbury; Robert W Freilich; Christopher J Cheng; Hirohide Asai; Seiko Ikezu; Jonathan D Boucher; Frank Slack; Tsuneya Ikezu
Journal:  J Neurosci       Date:  2015-07-01       Impact factor: 6.167

3.  miR-155 activates the NLRP3 inflammasome by regulating the MEK/ERK/NF-κB pathway in carotid atherosclerotic plaques in ApoE-/- mice.

Authors:  Qing Peng; Ruihua Yin; Xiaoyan Zhu; Liying Jin; Jing Wang; Xudong Pan; Aijun Ma
Journal:  J Physiol Biochem       Date:  2022-01-26       Impact factor: 4.158

4.  CREB1-driven expression of miR-320a promotes mitophagy by down-regulating VDAC1 expression during serum starvation in cervical cancer cells.

Authors:  Qin-Qin Li; Le Zhang; Hai-Ying Wan; Min Liu; Xin Li; Hua Tang
Journal:  Oncotarget       Date:  2015-10-27

5.  MiR-126 and miR-126* regulate shear-resistant firm leukocyte adhesion to human brain endothelium.

Authors:  Camilla Cerutti; Laura J Edwards; Helga E de Vries; Basil Sharrack; David K Male; Ignacio A Romero
Journal:  Sci Rep       Date:  2017-03-30       Impact factor: 4.379

6.  Denervation drives skeletal muscle atrophy and induces mitochondrial dysfunction, mitophagy and apoptosis via miR-142a-5p/MFN1 axis.

Authors:  Xiaofan Yang; Pingping Xue; Hongrui Chen; Meng Yuan; Yu Kang; Dominik Duscher; Hans-Günther Machens; Zhenbing Chen
Journal:  Theranostics       Date:  2020-01-01       Impact factor: 11.556

7.  Transformed extracellular vesicles with high angiogenic ability as therapeutics of distal ischemic tissues.

Authors:  Nhat-Hoang Ngo; Yun-Hsuan Chang; Cat-Khanh Vuong; Toshiharu Yamashita; Mana Obata-Yasuoka; Hiromi Hamada; Motoo Osaka; Yuji Hiramatsu; Osamu Ohneda
Journal:  Front Cell Dev Biol       Date:  2022-08-31

8.  Epigenetic silencing of microRNA-149 in cancer-associated fibroblasts mediates prostaglandin E2/interleukin-6 signaling in the tumor microenvironment.

Authors:  Pu Li; Jing-Xuan Shan; Xue-Hua Chen; Di Zhang; Li-Ping Su; Xiu-Ying Huang; Bei-Qin Yu; Qiao-Ming Zhi; Cheng-Long Li; Ya-Qing Wang; Sara Tomei; Qu Cai; Jun Ji; Jian-Fang Li; Lotfi Chouchane; Ying-Yan Yu; Fang-Zhen Sun; Zhi-Heng Xu; Bing-Ya Liu; Zheng-Gang Zhu
Journal:  Cell Res       Date:  2015-04-28       Impact factor: 25.617

9.  Circulating miRNAs Associated with Dysregulated Vascular and Trophoblast Function as Target-Based Diagnostic Biomarkers for Preeclampsia.

Authors:  Suji Kim; Minsik Park; Ji-Yoon Kim; Taesam Kim; Jong Yun Hwang; Kwon-Soo Ha; Moo-Ho Won; Sungwoo Ryoo; Young-Guen Kwon; Young-Myeong Kim
Journal:  Cells       Date:  2020-08-31       Impact factor: 6.600
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.